Project Grant R25CA291554
Award Date
7/30/25
Completion Date
6/30/30
Dollars Obligated
$315K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Alabama, USA
Similar Awards
This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $191,490 to the University of Kansas Medical Center Research Institute, Inc. to implement and evaluate a clinical workflow for screening and referring cancer patients with employment concerns to existing support resources. The project aims to: 1) conduct a patient-level needs and assets assessment, 2) evaluate implementation determinants at the clinic level, and 3) design and pilot...
The National Cancer Institute (NCI) awarded a $178,444 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of California, Los Angeles (UCLA) for the "UCLA SURGEON-SCIENTIST BASIC CANCER RESEARCH TRAINING PROGRAM (UCLA SURGEON-SCIENTIST BCRTP)". The program aims to provide rigorous curriculum and mentored research experiences to exceptional surgical residents dedicated to advancing cancer research and treatment innovation. The program...
The National Cancer Institute (NCI) awarded a $512,974 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Sloan-Kettering Institute for Cancer Research, a non-profit cancer research institution located in New York City. The grant, effective August 13, 2024 through July 31, 2029, will fund research to develop advanced predictive models for non-small cell lung cancer (NSCLC) outcomes using a combination of real-world data sources, including tumor genomic...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $388,712 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Dana-Farber Cancer Institute (DFCI) in Boston, MA. The "Young Empowered Scientists for Continued Research Engagement (YES for CURE)" program aims to increase participation and retention of underrepresented minority students in cancer-related STEM fields. The multi-year program will provide high school...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
This Project Grant award of $154,666.00 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will fund a study titled "Caregivers-Patients Support to Latinx Coping with Advanced-Cancer" at the Ponce Medical School Foundation Inc. in Puerto Rico. The goal is to refine and pilot a five-session, 60-minute telehealth intervention called CASA (Caregivers Patients Support to Latinx Coping with Advanced Cancer) for Hispanic/Latinx patients with advanced cancer...
This National Cancer Institute (NCI) Project Grant award under CFDA 93.395 "Cancer Treatment Research" provides $196,267 in funding to the University of California, Irvine (UCI) to advance novel cancer prevention and therapeutic strategies across NCI's clinical trial networks. The award will support the Principal Investigator's leadership roles on key NCI committees, completion of an ongoing Phase III clinical trial focused on preventing colorectal adenomas in a racially/ethnically...
This Project Grant award of $315,143.00 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports clinical trial research in the oncology landscape. The award, which has an ultimate completion date of August 31, 2029, is being provided to The Ohio State University, a leading public research university. Through this funding, The Ohio State University will conduct innovative cancer research focused on understanding cancer mechanisms, developing new diagnostic and...
The National Cancer Institute (NCI) awarded a $328,822 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Implenomics Llcs, a minority-owned, women-owned small business located in Marblehead, Massachusetts. The grant, effective September 20, 2024 through August 31, 2026, will fund the development and pilot testing of the Integrated Cancer Awareness Network (ICAN), an innovative mHealth platform. ICAN will provide cancer risk, symptom, and screening education to...